Accuray Incorporated (NASDAQ:ARAY)‘s stock had its “buy” rating reiterated by analysts at Jefferies Group LLC in a research note issued on Wednesday. They presently have a $7.00 target price on the medical equipment provider’s stock. Jefferies Group LLC’s target price points to a potential upside of 66.67% from the stock’s current price.

Several other brokerages have also commented on ARAY. Zacks Investment Research lowered shares of Accuray from a “buy” rating to a “hold” rating in a report on Tuesday, May 2nd. BidaskClub lowered shares of Accuray from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Finally, BTIG Research restated a “hold” rating on shares of Accuray in a report on Sunday, April 30th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $7.04.

Shares of Accuray (NASDAQ:ARAY) traded up 2.44% on Wednesday, hitting $4.20. The stock had a trading volume of 692,369 shares. The firm’s market capitalization is $348.60 million. Accuray has a 1-year low of $3.85 and a 1-year high of $6.39. The firm has a 50 day moving average of $4.52 and a 200-day moving average of $4.73.

TRADEMARK VIOLATION NOTICE: “Accuray Incorporated (NASDAQ:ARAY) Stock Rating Reaffirmed by Jefferies Group LLC” was published by Watch List News and is owned by of Watch List News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.watchlistnews.com/accuray-incorporated-nasdaqaray-stock-rating-reaffirmed-by-jefferies-group-llc/1466513.html.

Hedge funds have recently modified their holdings of the company. American International Group Inc. raised its stake in shares of Accuray by 7.1% in the first quarter. American International Group Inc. now owns 49,098 shares of the medical equipment provider’s stock valued at $233,000 after buying an additional 3,256 shares during the period. Cowen Prime Services LLC raised its stake in shares of Accuray by 12.6% in the first quarter. Cowen Prime Services LLC now owns 187,399 shares of the medical equipment provider’s stock valued at $890,000 after buying an additional 20,945 shares during the period. Engineers Gate Manager LP raised its stake in shares of Accuray by 196.9% in the first quarter. Engineers Gate Manager LP now owns 48,054 shares of the medical equipment provider’s stock valued at $228,000 after buying an additional 31,871 shares during the period. RNC Capital Management LLC raised its stake in shares of Accuray by 5.0% in the first quarter. RNC Capital Management LLC now owns 27,500 shares of the medical equipment provider’s stock valued at $131,000 after buying an additional 1,300 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in shares of Accuray by 8.4% in the first quarter. Bank of New York Mellon Corp now owns 640,505 shares of the medical equipment provider’s stock valued at $3,042,000 after buying an additional 49,719 shares during the period. Institutional investors and hedge funds own 84.64% of the company’s stock.

Accuray Company Profile

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy.

Analyst Recommendations for Accuray (NASDAQ:ARAY)

Receive News & Ratings for Accuray Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.